Quantitative determinants of the outcome of asymptomatic mitral regurgitation

被引:781
作者
Enriquez-Sarano, M
Avierinos, JF
Messika-Zeitoun, D
Detaint, D
Capps, M
Nkomo, V
Scott, C
Schaff, HV
Tajik, AJ
机构
[1] Mayo Clin, Div Cardiovasc Dis & Internal Med, Rochester, MN 55905 USA
[2] Mayo Clin, Div Cardiac Surg, Rochester, MN 55905 USA
[3] Mayo Clin, Biostat Sect, Rochester, MN 55905 USA
关键词
D O I
10.1056/NEJMoa041451
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND The clinical outcome of asymptomatic mitral regurgitation is poorly defined, and the treatment is uncertain. We studied the effect on the outcome of quantifying mitral regurgitation according to recent guidelines. METHODS We prospectively enrolled 456 patients (mean [+/-SD] age, 63+/-14 years; 63 percent men; ejection fraction, 70+/-8 percent) with asymptomatic organic mitral regurgitation, quantified according to current recommendations (regurgitant volume, 66+/-40 ml per beat; effective regurgitant orifice, 40+/-27 mm(sup 2)). RESULTS The estimated five-year rates (+/-SE) of death from any cause, death from cardiac causes, and cardiac events (death from cardiac causes, heart failure, or new atrial fibrillation) with medical management were 22+/-3 percent, 14+/-3 percent, and 33+/-3 percent, respectively. Independent determinants of survival were increasing age, the presence of diabetes, and increasing effective regurgitant orifice (adjusted risk ratio per 10-mm(sup 2) increment, 1.18; 95 percent confidence interval, 1.06 to 1.30; P<0.01), the predictive power of which superseded all other qualitative and quantitative measures of regurgitation. Patients with an effective regurgitant orifice of at least 40 mm(sup 2) had a five-year survival rate that was lower than expected on the basis of U.S. Census data (58+/-9 percent vs. 78 percent, P=0.03). As compared with patients with a regurgitant orifice of less than 20 mm(sup 2), those with an orifice of at least 40 mm(sup 2) had an increased risk of death from any cause (adjusted risk ratio, 2.90; 95 percent confidence interval, 1.33 to 6.32; P<0.01), death from cardiac causes (adjusted risk ratio, 5.21; 95 percent confidence interval, 1.98 to 14.40; P<0.01), and cardiac events (adjusted risk ratio, 5.66; 95 percent confidence interval, 3.07 to 10.56; P<0.01). Cardiac surgery was ultimately performed in 232 patients and was independently associated with improved survival (adjusted risk ratio, 0.28; 95 percent confidence interval, 0.14 to 0.55; P<0.01). CONCLUSIONS Quantitative grading of mitral regurgitation is a powerful predictor of the clinical outcome of asymptomatic mitral regurgitation. Patients with an effective regurgitant orifice of at least 40 mm(sup 2) should promptly be considered for cardiac surgery.
引用
收藏
页码:875 / 883
页数:9
相关论文
共 39 条
[1]  
[Anonymous], CIRCULATION S1, DOI 10.1161/hc37t1.094903
[2]   Natural history of asymptomatic mitral valve prolapse in the community [J].
Avierinos, JF ;
Gersh, BJ ;
Melton, LJ ;
Bailey, KR ;
Shub, C ;
Nishimura, RA ;
Tajik, AJ ;
Enriquez-Sarano, M .
CIRCULATION, 2002, 106 (11) :1355-1361
[3]   QUANTITATION OF MITRAL REGURGITATION BY DOPPLER ECHOCARDIOGRAPHY [J].
BLUMLEIN, S ;
BOUCHARD, A ;
SCHILLER, NB ;
DAE, M ;
BYRD, BF ;
PORTS, T ;
BOTVINICK, EH .
CIRCULATION, 1986, 74 (02) :306-314
[4]   Guidelines for the management of patients with valvular heart disease - Executive summary - A report of the American College of Cardiology American Heart Association task force on practice guidelines (committee on management of patients with valvular heart disease) [J].
Bonow, RO ;
Carabello, B ;
de Leon, AC ;
Edmunds, LH ;
Fedderly, BJ ;
Freed, MD ;
Gaasch, WH ;
McKay, CR ;
Nishimura, RA ;
O'Gara, PT ;
O'Rourke, RA ;
Rahimtoola, SH ;
Ritchie, JL ;
Cheitlin, MD ;
Eagle, KA ;
Gardner, TJ ;
Garson, A ;
Gibbons, RJ ;
Russell, RO ;
Ryan, TJ ;
Smith, SC .
CIRCULATION, 1998, 98 (18) :1949-1984
[5]   Contemporary approach to aortic and mitral regurgitation [J].
Borer, JS ;
Bonow, RO .
CIRCULATION, 2003, 108 (20) :2432-2438
[6]   SYNDROME OF SEVERE MITRAL REGURGITATION WITH NORMAL LEFT ATRIAL PRESSURE [J].
BRAUNWALD, E ;
AWE, WC .
CIRCULATION, 1963, 27 (01) :29-&
[7]   A NEW METHOD OF CLASSIFYING PROGNOSTIC CO-MORBIDITY IN LONGITUDINAL-STUDIES - DEVELOPMENT AND VALIDATION [J].
CHARLSON, ME ;
POMPEI, P ;
ALES, KL ;
MACKENZIE, CR .
JOURNAL OF CHRONIC DISEASES, 1987, 40 (05) :373-383
[8]   NATURAL-HISTORY OF SEVERE MITRAL REGURGITATION [J].
DELAHAYE, JP ;
GARE, JP ;
VIGUIER, E ;
DELAHAYE, F ;
DEGEVIGNEY, G ;
MILON, H .
EUROPEAN HEART JOURNAL, 1991, 12 :5-9
[9]  
Dujardin KS, 1997, CIRCULATION, V96, P3409
[10]   Progression of mitral regurgitation - A prospective Doppler echocardiographic study [J].
Enriquez-Sarano, M ;
Basmadjian, AJ ;
Rossi, A ;
Bailey, KR ;
Seward, JB ;
Tajik, AJ .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1999, 34 (04) :1137-1144